Ardent Health, Inc. Liquidation Value

ARDT Hospitals

Cash & Equivalents

$609.69M
As of 2026-03-31
Current Price: $9.91 (as of 2026-05-14)

Key Metrics

Cash Liquidation Value

Cash minus Total Obligations
Cash: $609.69M
Total Obligations: -$3.06B
$-2.45B
Per share: $-17.11
Period: 2026-03-31
incomplete 1 component missing — treated as $0 in formula. Why?
  • Finance Lease Liability: not reported in this period (annual-only)

Liquid Liquidation Value

Cash + AR minus Total Obligations
Cash: $609.69M
AR: $685.99M
Total Obligations: -$3.06B
$-1.76B
Per share: $-12.32
Period: 2026-03-31
incomplete 1 component missing — treated as $0 in formula. Why?
  • Finance Lease Liability: not reported in this period (annual-only)

Operating Liquidation Value

Cash + AR + Inventory minus Total Obligations
Cash: $609.69M
AR: $685.99M
Inventory: $119.84M
Total Obligations: -$3.06B
$-1.64B
Per share: $-11.48
Period: 2026-03-31
incomplete 1 component missing — treated as $0 in formula. Why?
  • Finance Lease Liability: not reported in this period (annual-only)

Build your own liquidation scenario

Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.

Open Calculator →

Liquidation Ladder

MetricTotalPer Share
Cash Liquidation Value$-2.45B$-17.11
Liquid Liquidation Value$-1.76B$-12.32
Operating Liquidation Value$-1.64B$-11.48

Key Components (as of 2026-03-31)

Data as of 2026-03-31 from 10-Q filed 2026-05-06. View on SEC EDGAR →

Cash & Equivalents$609.69M
Accounts Receivable$685.99M
Inventory$119.84M
Current Liabilities$951.48M
Long-term Debt (?)$1.07B
Op. Lease Liability (?)N/A
Finance Lease (?)$22.93M
Shares Outstanding143.1M

Explore all 109 XBRL tags and build your own scenario → Open Calculator

Historical

PeriodCashARInventoryAPCurr LiabLT DebtOp LeaseFin Lease
2026-03-31$609.69M$685.99M$119.84M$419.72M$951.48M$1.07BN/A$22.93M
2025-12-31$709.60M$686.10M$118.59M$457.94M$1.05B$1.08B$1.17B$13.41M
2025-09-30$609.44M$729.41M$121.59M$381.85M$943.15M$1.09BN/A$25.99M
2025-06-30$540.63M$758.64M$118.40M$364.45M$880.87M$1.09BN/A$28.65M

Comments

SEC Filings

PeriodFormFiledLink
2026-03-31 10-Q 2026-05-06 View
2025-12-31 10-K 2026-03-16 View
2025-09-30 10-Q 2025-11-14 View
2025-06-30 10-Q 2025-08-06 View
2025-03-31 10-Q 2025-05-07 View
2024-12-31 10-K 2025-02-27 View
2024-09-30 10-Q 2024-11-07 View
2024-06-30 10-Q 2024-08-14 View

AI Insights

AI Insight·Generated 2026-05-09

Ardent Health, Inc. (ARDT) is a for-profit acute care hospital operator with 30 hospitals across 6 states. Under a liquidation lens as of March 31, 2026, equity recovery is deeply negative. MFFAIS reports a cash liquidation value of approximately -$1.41B, liquid liquidation value of -$729M, and operating liquidation value of -$609M, confirming the structural deficit that is characteristic of capital-intensive, lease-heavy hospital operators. Total assets of $5.25B are dominated by intangibles and goodwill ($879M goodwill, $88M other intangibles) that receive zero recovery under liquidation haircuts, and PP&E net of depreciation of $923M that would recover at most 50-70% under distressed conditions. Total liabilities stand at $3.52B at face value, including $1.11B in financial debt (Term Loan B at $763.8M variable rate plus $400M in 5.75% Senior Notes due 2029), $22.9M finance lease liability, and an operating lease liability stack that is the single largest liability driver. The contractual obligations table discloses $2.84B in operating lease future payments, with $1.96B falling after five years under the Ventas Master Lease (10 hospitals, expiring August 2035) and MPT arrangement. Under liquidation accounting, these obligations do not extinguish and must be settled at face value, eliminating the benefit of any lease fair value discount. The self-insurance liability schedule discloses $208M in estimated self-insurance obligations (professional, general, and workers' compensation); the prior 10-K disclosed a $51.3M adverse prior-period development charge in professional liability accruals tied specifically to New Mexico market claims, creating tail risk above reported reserves. On the liquidity side, $609.7M in cash at quarter-end provides a meaningful buffer relative to the 1.0x net leverage ratio reported by management, but the lease-adjusted net leverage of 2.6x more accurately reflects the full claim stack. Q1 2026 operating cash flow was -$60.2M versus -$24.8M in Q1 2025, driven by working capital outflows from insurance premium renewals and Medicaid assessment timing; this is seasonal but directionally unfavorable. Two litigation matters — a securities class action (Postiwala) and derivative action (Thompson), both filed in 2026 — allege misstatement of accounts receivable and insurance reserves in 2024-2025. No XBRL tags for these contingent liabilities appear in the filing's tag set; they are disclosed only in narrative. Filing discusses operating lease commitments and self-insurance liabilities extensively in MD&A but the operating lease liability balance is embedded within OtherAccruedLiabilitiesCurrent and LongTermDebtNoncurrent rather than tagged as a standalone OperatingLeaseLiability concept in this quarter's XBRL emission — that absence warrants attention when building a full liability stack model.

Flags

Loading flags...

AI Insight Discussion

Loading...

Community Notes

Loading notes...

Questions

Loading questions...